@freddiechen's estradiol injection guide, fact-checked

What did @freddiechen actually say?

@freddiechen walked through a weekly subcutaneous estradiol valerate injection, covering needle swaps, aspiration technique, air bubble prevention, and disposal. She described being on "monotherapy," meaning estrogen alone suppresses her testosterone without an anti-androgen. She also mentioned that "injections just anecdotally tend to be more efficacious" than oral pills, flagged DIY HRT as a real option, and encouraged viewers to start HRT quickly given political pressures on access. She did consistently tell viewers to talk to a doctor, which is worth noting.

The video is a practical how-to, not a medical lecture. Most of what she describes is recognizable standard practice among patients who self-administer injectable hormones, but a few technical points are either imprecise or outright wrong.

Does the science back this up?

Mostly, yes, with real caveats. Injectable estradiol valerate does produce more stable, predictable serum levels than oral estradiol in most patients, and the liver first-pass metabolism concern for oral estrogen is legitimate. A 2019 systematic review by Nota et al. in The Lancet Diabetes and Endocrinology found injectable estradiol formulations produced significantly more consistent serum levels than oral routes in transgender women.

Monotherapy, meaning estrogen suppressing testosterone to female reference ranges without anti-androgens, is pharmacologically plausible and is supported by clinical evidence at adequate doses. Wierckx et al. (2014, Journal of Sexual Medicine) documented that high-dose estradiol can achieve testosterone suppression in a meaningful proportion of patients without additional anti-androgens. It does not work for everyone, and assuming monotherapy will work without monitoring labs is a real risk the video glosses over.

The claim that sublingual estradiol avoids liver metabolism is accurate. Oral estradiol swallowed whole does undergo significant first-pass hepatic metabolism, raising sex hormone binding globulin and potentially clotting factor levels more than injectable routes (Leinung et al., 2018, Endocrine Practice).

What did they get wrong (or right)?

The aspiration technique she describes, pushing air into the vial to create a vacuum and reduce bubbles, is actually standard practice for drawing oil-based injectables. Credit where it is due.

However, she says "draw some malphurs" during aspiration, which appears to be a garbled reference to aspirating the syringe after insertion to check for blood return. This is the correct safety step, but her explanation is genuinely unclear and could confuse first-time injectors. More importantly, current nursing and clinical guidelines have moved away from mandatory aspiration for intramuscular injections in most sites, though many patients still use it as a personal check. It is not wrong, just no longer universally recommended (World Health Organization Best Practices for Injections, 2010).

She injects into her thigh and describes it as intramuscular. Fine. But she says "also walk around if you have to, helps your leg not be so sore." That is anecdotal and not meaningfully supported by evidence on post-injection myalgia for oil-based hormones.

The DIY HRT comment, "it's not dangerous though, it's just the wrong ingredients and knowing how to use it," is too casual. Unregulated hormone sources carry real risks of contamination, incorrect concentration, and no oversight for cardiovascular or hepatic monitoring.

What should you actually know?

If you are starting or managing injectable estradiol, the route and formulation matter clinically. Estradiol valerate dosed weekly is a reasonable protocol, but the right interval and dose depend on your labs, not on how you feel day to day. Relying on subjective symptoms, breakouts, irritability, as your primary dosing signal is not a substitute for serum estradiol and testosterone monitoring.

The monotherapy point deserves a direct flag: some patients achieve testosterone suppression on estrogen alone, and some do not. Without bloodwork, you cannot tell which category you are in. A provider who actually checks labs is the minimum standard here, not optional context.

On cost and access, her $60 figure for estradiol and progesterone reflects what is available through some telehealth platforms or compounding pharmacies. Prices vary significantly, and compounded hormone preparations are not equivalent to FDA-approved branded formulations in terms of regulatory oversight. That distinction matters if something goes wrong.

• Dispose of needles in a proper sharps container. This is not optional.
• Oil-based injectables like estradiol valerate can cause injection site reactions. Rotating sites is standard practice, not just a preference.
• If you experience chest pain, shortness of breath, or leg swelling after starting injectable estrogen, seek care immediately. Venous thromboembolism risk, while lower with injectable than oral estrogen, is not zero.